Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The study record history continues to show the trial’s version list and the sections updated in each version.
    Difference
    0.0%
    Check dated 2026-10-03T14:17:34.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision history updated: a new entry 'Revision: v3.7.0' has been added and an older entry 'Revision: v3.6.6' removed, reflecting the latest version in the study record history.
    Difference
    0.0%
    Check dated 2026-09-19T18:11:38.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The record history now includes updates for Study Design, Study Status, and Recruitment Status, reflecting new structured status information for the trial. The study's status has been changed from Active, not recruiting to Completed.
    Difference
    0.3%
    Check dated 2026-08-29T18:55:39.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The history now shows a new latest revision, v3.6.5, added to the list. The previous revision v3.6.4 has been removed from the history.
    Difference
    0.0%
    Check dated 2026-08-08T19:23:16.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    A new revision label (v3.6.4) was added to the history, replacing the previous v3.6.3 label. This reflects an update to the page's revision metadata rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T11:36:47.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    The revision label in the page footer changed to v3.6.3, indicating a minor site build update rather than a content change.
    Difference
    0.0%
    Check dated 2026-07-03T22:57:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.